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Introduction: Secondary mitral regurgitation (MR) is a dynamic myocardial disease accompanying 
cardiomyopathy and coronary artery disease.1-4
Case report: We present a case of 63-year-old patient with long standing cardiomyopathy after breast 
cancer chemotherapy. Her left ventricle (LV) is slightly dilated with moderately impaired systolic func-
tion (estimated EF 30%) and severe diastolic disfunction. Significant MR (Figure 1, Figure 2) has been 
present for years but patient’s condition deteriorated rapidly with frequent admissions for heart failure 
despite optimal medical therapy. Upon last discharge echocardiography showed slight improvement 
in LV systolic function and persistent severe secondary MR. She has no significant coronary artery 
disease or indication for CRT. 
Discussion and Conclusion: Severe secondary MR is in most cases treated conservatively, especially 
in the absence of other surgical indication. According to guidelines mitral valve intervention (surgery 
or transcatheter procedure) may be considered in refractory cases after heart team discussion. Our 
patient was subsequently scheduled for mitral valve replacement.
Figure 1. parasternal long axis view showing dilated left 
ventricle and significant mitral regurgitation into dilated left 
atrium.
Figure 2. Mitral quantification using the proximal isovelocity 
surface area (PISA) method – effective regurgitant orifice area 
(eROA) 0.5 cm2, right ventricle (Rv) 57 ml.
